Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:16 AM
Ignite Modification Date:
2025-12-25 @ 1:16 AM
NCT ID:
NCT03909893
Eligibility Criteria:
Inclusion Criteria:
1. Histologic diagnosis of adenocarcinoma of the prostate after radical prostatectomy:
* Clinical stage pT3, pT4, or pT2 with positive margin; OR,
* any p-stage with persistently elevated post-operative PSA \> 0.05ng/mL; OR,
* a delayed rise in PSA post-operative
2. Histologic diagnosis of transitional cell carcinoma of the bladder with intact bladder and:
* Clinical stage cT2, cT3, cT4, and N0 or N1
Exclusion Criteria:
1. Inflammatory bowel disease or other contraindications to radiotherapy.
2. Prior pelvic radiotherapy
3. Previous cytotoxic chemotherapy
4. Evidence of systemic metastases on imaging
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03909893
Study Brief:
Protocol Section:
NCT03909893